Cetuximab-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of K-ras mutations
作者： Ezzeldin M. Ibrahim , Jamal M. Zekri , Bakr M. Bin Sadiq
DOI: 10.1007/S00384-010-0927-4
关键词: Oncology 、 Colorectal cancer 、 Internal medicine 、 Cetuximab 、 Hepatology 、 Meta-analysis 、 Medicine
摘要: Background Cetuximab has a favorable effect on patients with metastatic colorectal cancer harboring wild K-ras gene. This meta-analysis was planned to quantify the benefit.
springer.com
sci-hub.se 参考文章(36)
Joseph Lau, John PA Ioannidis, Christopher H Schmid, Quantitative Synthesis in Systematic Reviews Annals of Internal Medicine. ,vol. 127, pp. 820- 826 ,(1997) , 10.7326/0003-4819-127-9-199711010-00008
Lidan Liu, Yunfei Cao, Aihua Tan, Cun Liao, Feng Gao, Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials. Cancer Chemotherapy and Pharmacology. ,vol. 65, pp. 849- 861 ,(2010) , 10.1007/S00280-009-1090-X
F Di Fiore, F Blanchard, F Charbonnier, F Le Pessot, A Lamy, M P Galais, L Bastit, A Killian, R Sesboüé, J J Tuech, A M Queuniet, B Paillot, J C Sabourin, F Michot, P Michel, T Frebourg, Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy. British Journal of Cancer. ,vol. 96, pp. 1166- 1169 ,(2007) , 10.1038/SJ.BJC.6603685
J. Randolph Hecht, Edith Mitchell, Tarek Chidiac, Carroll Scroggin, Christopher Hagenstad, David Spigel, John Marshall, Allen Cohn, David McCollum, Philip Stella, Robert Deeter, Seta Shahin, Rafael G. Amado, A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 27, pp. 672- 680 ,(2009) , 10.1200/JCO.2008.19.8135
J-L Yang, Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon Gut. ,vol. 53, pp. 123- 129 ,(2004) , 10.1136/GUT.53.1.123
Irena Porębska, Antonina Harłozińska, Tomasz Bojarowski, Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas. Tumor Biology. ,vol. 21, pp. 105- 115 ,(2000) , 10.1159/000030116
Justin M Balko, Esther P Black, A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer BMC Cancer. ,vol. 9, pp. 145- 145 ,(2009) , 10.1186/1471-2407-9-145
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74
Neal S. Goldstein, Maryiam Armin, Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer. ,vol. 92, pp. 1331- 1346 ,(2001) , 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M
David S. Salomon, Ralf Brandt, Fortunato Ciardiello, Nicola Normanno, Epidermal growth factor-related peptides and their receptors in human malignancies Critical Reviews in Oncology Hematology. ,vol. 19, pp. 183- 232 ,(1995) , 10.1016/1040-8428(94)00144-I